Neuropeptides activate human mast cell degranulation and chemokine production

被引:407
作者
Kulka, Marianna [1 ]
Sheen, Cecilia H. [2 ]
Tancowny, Brian P. [2 ]
Grammer, Leslie C. [2 ]
Schleimer, Robert P. [2 ]
机构
[1] Natl Res Council Canada, Charlottetown, PE C1A 4P3, Canada
[2] Northwestern Univ, Feinberg Sch Med, Div Allergy Immunol, Chicago, IL 60611 USA
关键词
mast cells; IgE; substance P; VIP; chemokines; neuropeptides;
D O I
10.1111/j.1365-2567.2007.02705.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
During neuronal-induced inflammation, mast cells may respond to stimuli such as neuropeptides in an Fc epsilon RI-independent manner. In this study, we characterized human mast cell responses to substance P (SP), nerve growth factor (NGF), calcitonin gene-related peptide (CGRP) and vasoactive intestinal polypeptide (VIP) and compared these responses to human mast cell responses to immunoglobulin E (IgE)/anti-IgE and compound 48/80. Primary cultured mast cells, generated from CD34(+) progenitors in the presence of stem cell factor and interleukin-6 (IL-6), and human cultured mast cells (LAD2) were stimulated with these and other stimuli (gastrin, concanavalin A, radiocontrast media, and mannitol) and their degranulation and chemokine production was assessed. VIP and SP stimulated primary human mast cells and LAD cells to degranulate; gastrin, concanavalin A, radiocontrast media, mannitol, CGRP and NGF did not activate degranulation. While anti-IgE stimulation did not induce significant production of chemokines, stimulation with VIP, SP or compound 48/80 potently induced production of monocyte chemoattractant protein-1, inducible protein-10, monokine induced by interferon-gamma (MIG), RANTES (regulated on activation, normal, T-cell expressed, and secreted) and IL-8. VIP, SP and compound 48/80 also activated release of tumour necrosis factor, IL-3 and granulocyte-macrophage colony-stimulating factor, but not IL-4, interferon-gamma or eotaxin. Human mast cells expressed surface neurokinin 1 receptor (NK1R), NK2R, NK3R and VIP receptor type 2 (VPAC2) but not VPAC1 and activation of human mast cells by IgE/anti-IgE up-regulated expression of VPAC2, NK2R, and NK3R. These studies demonstrate the pattern of receptor expression and activation of mast cell by a host of G-protein coupled receptor ligands and suggest that SP and VIP activate a unique signalling pathway in human mast cells. These results are likely to have direct relevance to neuronally induced inflammatory diseases.
引用
收藏
页码:398 / 410
页数:13
相关论文
共 66 条
[1]
Regulation of chymase production in human mast cell progenitors [J].
Ahn, K ;
Takai, S ;
Pawankar, R ;
Kuramasu, A ;
Ohtsu, H ;
Kempuraj, D ;
Tomita, H ;
Iida, M ;
Matsumoto, K ;
Akasawa, A ;
Miyazaki, M ;
Saito, H .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 106 (02) :321-328
[2]
Andoh T, 1998, J PHARMACOL EXP THER, V286, P1140
[3]
Mast cell deficient and neurokinin-1 receptor knockout mice are protected from stress-induced hair growth inhibition [J].
Arck, PC ;
Handjiski, B ;
Kuhlmei, A ;
Peters, EMJ ;
Knackstedt, M ;
Peter, A ;
Hunt, SP ;
Klapp, BF ;
Paus, R .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2005, 83 (05) :386-396
[4]
Bebo BF, 1996, J NEUROSCI RES, V45, P340
[5]
Beck LA, 1997, J IMMUNOL, V159, P2962
[6]
MAST CELL/NERVE INTERACTIONS INVITRO AND INVIVO [J].
BIENENSTOCK, J ;
MACQUEEN, G ;
SESTINI, P ;
MARSHALL, JS ;
STEAD, RH ;
PERDUE, MH .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 143 (03) :S55-S58
[7]
Substance P and other neuropeptides do not induce mediator release in isolated human intestinal mast cells [J].
Bischoff, SC ;
Schwengberg, S ;
Lorentz, A ;
Manns, MP ;
Bektas, H ;
Sann, H ;
Levi-Schaffer, F ;
Shanahan, F ;
Schemann, M .
NEUROGASTROENTEROLOGY AND MOTILITY, 2004, 16 (02) :185-193
[8]
Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor [J].
Cao, J ;
Papadopoulou, N ;
Kempuraj, D ;
Boucher, WS ;
Sugimoto, K ;
Cetrulo, CL ;
Theoharides, TC .
JOURNAL OF IMMUNOLOGY, 2005, 174 (12) :7665-7675
[9]
SYNTHESIS AND BIOLOGICAL-ACTIVITIES OF SUBSTANCE-P ANTAGONISTS [J].
CARANIKAS, S ;
MIZRAHI, J ;
ESCHER, E ;
REGOLI, D .
JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (11) :1313-1316
[10]
Substance P-related inhibitors of mast cell exocytosis act on G-proteins or on the cell surface [J].
Chahdi, A ;
Mousli, M ;
Landry, Y .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 341 (2-3) :329-335